International Congress of Parkinson's Disease and Movement Disorders
The role of risvodetenib in the treatment of Parkinson’s disease and other CNS diseases
Enrolling treatment-naïve patients in Parkinson’s disease clinical trials
Phase II study of risvodetinib in Parkinson’s disease
Analysis of the therapeutic potential of c-Abl inhibition in Parkinson’s disease & MSA